University of Sheffield

Global Journal Observatory: Better Understanding the Research Ecosystem

Retrieved on: 
Monday, March 4, 2024
Beijing Normal University, Publishing, Research, COPE, Information school, IMR, PLOS, Science and Technology Daily, Multimedia, SAGE Publishing, Science, Culture, Sale, Leiden University, University of Sheffield, Alphonse, Springer Nature, Perception, University, Information science, Factorization of polynomials, Improper integral, IOP Publishing, Organization, Journal, Thelwall, Civilization, Publication, Environment, Management

BEIJING, March 4, 2024 /PRNewswire/ -- Ronald Rousseau, the Co-Editor-in-Chief of the JDIS, shared his insights as follow:  

Key Points: 
  • Science and Technology Daily has launched a new column, Global Journal Observatory, with the National Science Library of the Chinese Academy of Sciences.
  • For the sake of better science, the JDIS has initiated a series of activities to respond to and reverse this situation.
  • During the event, a memorandum of understanding was signed, signaling the collaborative effort required to safeguard the integrity of scientific research.
  • All of these initiatives serve our ultimate goal, that is, enabling researchers to publish the best possible scientific research to create a better life.

Virgin Atlantic flies world's first 100% Sustainable Aviation Fuel flight from London Heathrow to New York JFK

Retrieved on: 
Tuesday, November 28, 2023
Aviation, Carbon, Aviation biofuel, Waste, Dicarboxylic acid, Research, Policy, Hope, Food chain, Hydrogen, Boeing 787 Dreamliner, ICF, Contrail, Port, Quercus ser. Virentes, Virgin Atlantic, Ester, Rolls-Royce Holdings, CO2, Petroleum, Rolls-Royce Trent 1000, Government, Virgin Unite, RMI, Sugar, SAF, RMI (energy organization), SAK, Inflation, Hamilton-Oshawa Port Authority, Marathon Petroleum, University, Sustainability, Partnership, Imperial College London, Gross value added, Rolls-Royce, Transport, University of Sheffield, Jet fuel, Airline, Renewable energy, Atlantic Ocean, Engineering, Boeing

NEW YORK, Nov. 28, 2023 /PRNewswire/ -- Virgin Atlantic's historic flight on 100% Sustainable Aviation Fuel (SAF) takes off from London Heathrow to New York JFK today, marking the culmination of a year of radical collaboration, to demonstrate the capability of SAF as a safe drop-in replacement for fossil-derived jet fuel, compatible with today's engines, airframes and fuel infrastructure.

Key Points: 
  • Flight100 proves Sustainable Aviation Fuel (SAF) is a safe drop-in replacement for fossil-derived jet fuel and the only viable mid-term solution for decarbonizing long-haul aviation.
  • Shai Weiss, Chief Executive Officer, Virgin Atlantic said: "Flight100 proves that Sustainable Aviation Fuel can be used as a safe, drop-in replacement for fossil-derived jet fuel and it's the only viable solution for decarbonizing long-haul aviation.
  • "Virgin Atlantic has been challenging the status quo and pushing the aviation industry to never settle and do better since 1984.
  • The flight represents a major milestone for the entire aviation industry in its journey towards net zero carbon emissions."

6th Annual Neuroscience R&D Conference, London, United Kingdom - October 9-10, 2023

Retrieved on: 
Thursday, September 21, 2023
Interactivity, University, Therapy, Senior, Blood–brain barrier, Proteomics, CNS, Assistant, University of Nottingham, Patient, Access, University of Sheffield, Drug discovery, Neurology, AI, Conference, Alzheimer's disease, University of Oxford, Medical device, Pharmaceutical industry, Neuroscience, Translational neuroscience

DUBLIN, Sept. 21, 2023 /PRNewswire/ -- The "Neuroscience R&D Conference" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Sept. 21, 2023 /PRNewswire/ -- The "Neuroscience R&D Conference" conference has been added to ResearchAndMarkets.com's offering.
  • With the advent of neural implants and novel therapies, the cure of multiple neurodegenerative disorders proves wholesome for the patients' suffering.
  • The increasing in severity of neurodegenerative diseases, demands the discovery of new translational approaches in neuroscience research.
  • Case studies presented from leading technology collaborations, Interactive panels, and breakout sessions along with Access to online presentations on-demand post-summit.

NeuroMetrix Reports Q2 2023 Business Highlights

Retrieved on: 
Thursday, July 27, 2023
Risk, CMS, University, Exercise-associated muscle cramps, Diabetes, Centers for Medicare & Medicaid Services, Telephone, RCT, DSM-IV codes, Type 2 diabetes, Center for Medicare and Medicaid Innovation, Prescription, Research, CIPN, COVID, Medicare, Peripheral edema, PIN, Traction, Patient, Financial result, Randomized controlled trial, Sheffield, Peripheral neuropathy, Dentistry, Growth, Mortality, Diabetic retinopathy, FDA, NIH, Kidney disease, University of Sheffield, Pharmaceutical industry, Quell

WOBURN, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported business and financial highlights for the quarter and six months period ended June 30, 2023.

Key Points: 
  • WOBURN, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported business and financial highlights for the quarter and six months period ended June 30, 2023.
  • Revenue in Q2 2023 of $1.7 million was lower by $0.5 million or 23% from Q2 2022 primarily due to reduced sales volume for DPNCheck in the Medicare Advantage market.
  • The gross margin rate of 68% in Q2 2023 was flat with Q2 2022.
  • The Q2 2023 net loss was $1.5 million ($0.19 per share) versus a net loss of $1.2 million ($0.17 per share) in Q2 2022.

WORLD FIRST 100% SAF TRANSATLANTIC FLIGHT SETS SIGHTS ON TAKEOFF

Retrieved on: 
Thursday, July 20, 2023
RMI (energy organization), Travel, University, Rolls-Royce Trent 1000, General counsel, SAF, Aviation, Rolls-Royce, Policy, Transport, Virgin Atlantic fleet, Research, SAK, Carbon, Government, Dicarboxylic acid, Atmosphere of Earth, Aviation biofuel, Heathrow Airport, University of Sheffield, Quercus ser. Virentes, Deep Decarbonization Pathways Project, Civil Aerospace Medical Institute, Boeing 787 Dreamliner, Air BP, John F. Kennedy International Airport, CO2, Imperial College London, Jet fuel, Airline, Boeing, Sustainability, Virgin Atlantic, Atlantic Ocean

NEW YORK, July 20, 2023 /PRNewswire/ -- Virgin Atlantic and Rolls-Royce today confirm the successful Sustainable Aviation Fuel (SAF) blend ground test on the Rolls-Royce Trent 1000 engine. The test marks a key milestone in the project which will see the world's first 100% SAF flight travel across the Atlantic from London Heathrow to New York JFK on a Boeing 787, set to take off on November 28, 2023.

Key Points: 
  • Already operating one of the most fuel and carbon efficient fleets across the Atlantic, this flight builds on the airline's 15-year track record for leading on SAF.
  • Demonstrating that through radical collaboration, industry can deliver 100% SAF in today's engine, airframes and fuel infrastructure for long haul flight.
  • Virgin Atlantic and the consortium will leverage the 100% SAF transatlantic flight to further SAF use, as well as addressing other environmental impacts of the sector.
  • Andreea Moyes, Global Head of Sustainability, Air bp, said: "We are thrilled to be supplying Sustainable Aviation Fuel for the world's first 100% SAF transatlantic flight.

Aeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate Update

Retrieved on: 
Thursday, July 13, 2023
Immortalised cell line, GMP, University of Sheffield, FRCP, Contract research organization, PD, Metabolism, Survival, Clinical trial, Immune tolerance, Hypoparathyroidism, Quality of life, Neuroimmunology, NMOSD, Calcium, PTH, Autoimmunity, MD, Patient, Division, Novo Nordisk, Disease, Toxicology, TSX, Birth, Mortality, Diagnosis, Hospital, Massachusetts General Hospital, IND, Safety, Fine chemical, Pharmaceutical industry, Vaccine, Medical device, Generic drug, Birth control, Silviculture, ALS

“We are encouraged by our significant progress across all of our active development programs, and based on the prioritization of our pipeline, have strengthened our focus on our diagnostic and therapeutic programs as we execute on key decision points,” commented Dr. Klaus Paulini, Chief Executive Officer of Aeterna.

Key Points: 
  • “We are encouraged by our significant progress across all of our active development programs, and based on the prioritization of our pipeline, have strengthened our focus on our diagnostic and therapeutic programs as we execute on key decision points,” commented Dr. Klaus Paulini, Chief Executive Officer of Aeterna.
  • This approach is based on induction of selective and highly target-specific immune de-sensibilization based on the natural concept of feto-maternal tolerance.
  • Together, we look forward to furthering the development of this program.”
    Demonstrated positive pre-clinical proof-of-concept in various in-vitro and in-vivo models.
  • “We remain focused on advancing our programs to their next phase of development, guided by the data and financial risk/reward as we do so.

Medimaps Group Deep-tech TBS Software Endorsed by International Experts Working Group To Inform Osteoporosis Management Decisions for The Benefit of The Patient

Retrieved on: 
Wednesday, July 5, 2023
Health, Medical Devices, Technology, Other Health, Software, General Health, Biotechnology, Osteoporosis International, Moyamoya disease, University of Sheffield, Systematic review, Bone, Hip, Chronic kidney disease, DSM-IV codes, Metabolism, Bone fracture, Epidemiology, McCloskey, Type 2 diabetes, Bone density, Woman, IOF, TBS, Trabecula, BMD, Archive, International Osteoporosis Foundation, Dementia, FRAX, Kanis, Patient, Risk, Archives of Osteoporosis, Fracture, Diagnosis, Mortality, WHO, European Society for Medical Oncology, Death, Medical device, Dietary supplement, Dentistry, Adult, Osteoporosis, Ageing, Osteoarthritis

The peer-reviewed article provides endorsed guidance to clinicians looking to enhance the assessment and management of osteoporosis with Medimaps Group TBS iNsight™ software for patient benefit.

Key Points: 
  • The peer-reviewed article provides endorsed guidance to clinicians looking to enhance the assessment and management of osteoporosis with Medimaps Group TBS iNsight™ software for patient benefit.
  • Worldwide, osteoporosis causes more than 8.9 million fractures every year, resulting in an osteoporosis fracture every 3 seconds.
  • The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study.
  • Osteoporosis International, 32, pp.251-25
    Harvey, et al., 2015, Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice, Bone , Volume 78 , Pages 216-224

Diabetic Peripheral Neuropathy Screening That Includes DPNCheck® Predicts Mortality In A Prospective Clinical Study

Retrieved on: 
Wednesday, June 7, 2023
Learning, University, PCR, Research, Risk, DPN, Patient, University of Sheffield, Peripheral neuropathy, Mortality, Poster, Glycated hemoglobin, Pharmaceutical industry, Diabetes

The scientific poster was titled "Abnormal combined diabetic peripheral neuropathy (DPN)-check and SUDOSCAN results predict all-cause mortality in people with diabetes: The Sheffield prospective study."

Key Points: 
  • The scientific poster was titled "Abnormal combined diabetic peripheral neuropathy (DPN)-check and SUDOSCAN results predict all-cause mortality in people with diabetes: The Sheffield prospective study."
  • The study prospectively followed 245 individuals with diabetes for 7-years following screening for peripheral neuropathy.
  • The screening tests included a structured clinical exam (Toronto Clinical Neuropathy Score, TCNS), the Semmes-Weinstein Monofilament test (10 g-MFT) that is a subjective, clinical test for DPN, a device (Sudoscan®) that measures autonomic nerve function, and DPNCheck.
  • The study authors concluded, "This is the first prospective study to show abnormal combined DPN-Check and Sudoscan results predict all-cause mortality, even after adjustment for other risk factors.

Eion Awarded Industry-First Patent for Measurement Methodology to Unlock Scalable Carbon Removal Solution

Retrieved on: 
Thursday, May 11, 2023
Mineral, University, University of California, Berkeley, ERW, Farmer, USDA-ARS, Agriculture, Carbon, University of Illinois Urbana-Champaign, SGS, Certification, Organization, CO 2, CDR, Sustainability, Soil, Atmosphere, University of Sheffield, Florida Institute for Sustainable Energy, CO2, Entrepreneurship, MRV, Environment, Health, UIUC, University of Nebraska–Lincoln, Fertilizer, Eion, Rutgers University

OAKLAND, Calif., May 11, 2023 /PRNewswire/ -- Eion, a carbon removal company scaling enhanced rock weathering (ERW) on agricultural lands, today announced its industry-first patent to directly measure carbon removal through ERW. Eion is working with farmers and existing agricultural systems to rapidly scale carbon dioxide removal (CDR) to meet Net Zero goals while improving soil health and creating jobs in rural communities.

Key Points: 
  • OAKLAND, Calif., May 11, 2023 /PRNewswire/ -- Eion , a carbon removal company scaling enhanced rock weathering (ERW) on agricultural lands, today announced its industry-first patent to directly measure carbon removal through ERW.
  • "Our measurement methodology unlocks enhanced rock weathering for the benefit of the global climate and local communities," said Adam Wolf, Co-Founder and CEO of Eion.
  • In 2022, Eion removed 500 tons of carbon dioxide, and in 2023, it will deliver another 8,500 tons of verifiable removal employing its patented measurement methodology.
  • Eion is committed to scientific collaboration with ERW stakeholders on important endeavors related to MRV that will unlock scale for this critical carbon removal pathway.

SCIENCE BASED INDUSTRIES JOIN FORCES FOR FIRST TIME TO ADDRESS UK NET ZERO TARGETS

Retrieved on: 
Thursday, February 2, 2023
Carbon, Society, Pulp and paper industry in Europe, Glass, University of Sheffield, Challenge, University of Surrey, Sky Sci-Fi, SMCP Group, University, SCI, Electronics, Centre for Process Innovation, Chemical industry, Innovation, Paper, Industrial waste, TFI, Confederation, Reckitt, Tata Steel, UPM (company), Metal, Chemistry, Procter & Gamble, BASF, Coal, Innovate UK, Natural gas, Renewable energy, Unilever, Croda International

The project, which has been granted £2.68 million from Innovate UK, will aim to help the UK reach its net zero target.

Key Points: 
  • The project, which has been granted £2.68 million from Innovate UK, will aim to help the UK reach its net zero target.
  • One goal is to seek to demonstrate how the UK could cut around 15 – 20 million tonnes of carbon dioxide emissions a year to help reach its net zero target.
  • If the UK is to reach its net zero target by 2050, industries must find an alternative source for the carbon in these goods.
  • Securing an alternative domestic source of carbon in these goods is one way in which these sectors can contribute to net zero targets, while also building a new UK value chain.